DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

	June 30, 2023
Common shares issuable upon exercise of employee and non-employee stock options		3,643,513
Common shares issuable upon settlement of deferred stock units		213,905
Common shares issuable upon vesting of restricted stock units		8,578
Common shares issuable upon exercise of common share purchase warrants		205,000
Shares available for grant under the 2019 Omnibus Incentive Plan		1,157,215
Shares available for grant under the 2021 Employment Inducement Incentive Plan		395,000
Total		5,623,211